Currently, the construction and design of prostate-cancer-targeted microbubbles have mostly focused on target molecules implicated in angiogenesis, including targeted microbubbles that carry vascular endothelial growth factor receptor type 2 (VEGFR2) antibody. Here, KDR is linked to prostate cancer.